BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-474@pharmaconomics
DTSTAMP:20260707T003512Z
DTSTART;VALUE=DATE:20260731
DTEND;VALUE=DATE:20260801
SUMMARY:REPL AdCom — RP1 (estimated date)
DESCRIPTION:An FDA advisory committee reviews RP1 for advanced melanoma around ~ Jul 31\, 2026. The panel's public vote often front-runs the agency's final verdict — and the share price.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1737953/000110465926078511/tm2619129d1_ex99-1.htm\n\nTrack it: https://pharmaconomics.com/e/474
URL:https://pharmaconomics.com/e/474
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:REPL catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR